Vancomycin

22 registered clinical trials studyying Vancomycin — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing NCT07120490	Medical University of Warsaw	N/A
Recruiting	Vancomycin Reduction Practices (VRP) in the NICU NCT06772675	Children's Hospital of Philadelphia	N/A
Completed	Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes NCT06069206	Vanderbilt University Medical Center	N/A
Not Yet Recruiting	First Time Right of Vancomycin NCT05964114	Erasmus Medical Center	N/A
Completed	Continuous vs. Intermittent Infusion Vancomycin NCT05823116	Aaron Cook	Phase 4
Suspended	Intracameral Antibiotic Safety Study NCT02590523	Panhandle Eye Group, LLP	Phase 3
Completed	Clinical Decision Support Tool for Vancomycin Dosing in Children NCT04911270	University of Maryland, Baltimore	N/A
Completed	The Clinical Validation of a Dried Blood Spot Method for Vancomycin and Creatinine NCT05257070	Erasmus Medical Center	—
Completed	Model-informed Precision Dosing of Vancomycin in Adults NCT05535075	University Hospital, Ghent	Phase 4
Completed	Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospi NCT04756895	CR-CSSS Champlain-Charles-Le Moyne	N/A
Unknown	Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology NCT04758442	Ciusss de L'Est de l'Île de Montréal	N/A
Completed	Precision Dosing of Vancomycin in Critically Ill Children NCT04666948	University Hospital, Ghent	Phase 4
Completed	Intraosseous Vancomycin in Primary Total Hip Arthroplasty - Designing a Protocol NCT04042233	The Methodist Hospital Research Institute	Phase 4
Unknown	Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China NCT03456544	Peking University First Hospital	—
Unknown	Intrawound Vancomycin Prophylaxis for Neural Stimulator NCT03221023	University of British Columbia	Phase 2 / Phase 3
Completed	Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibio NCT02951702	St. Luke's Hospital, Chesterfield, Missouri	Phase 4
Recruiting	Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO) NCT06426836	University Hospital, Ghent	N/A
Unknown	Vancomycin in the Target Site Treatment of Intracranial Infection NCT03585426	Xijing Hospital	Phase 4
Terminated	Optimal Treatment for Recurrent Clostridium Difficile NCT02667418	VA Office of Research and Development	Phase 4
Completed	The Influencing Factors of Vancomycin Trough Level and the Rate Achieving the Target Trough Level NCT03806543	Southeast University, China	—
Completed	Pharmacokinetics of Preoperative Vancomycin NCT03453684	University of Colorado, Denver	Phase 4
Recruiting	Antibiotic Dosing in Pediatric Intensive Care NCT02456974	University Hospital, Ghent	—